drugset / Trial / NCT04631354
Study in Healthy Adults to Quantify Lung Deposition and Distribution of Radio-labelled S-770108 Inhalation Powder Formulation Delivered by a Novel Inhaler Device
RandomizedCrossoverOpen-labelOther
Summary
The primary objective of this study is to assess the total lung deposition of radiolabelled S-770108 inhalation powder formulation after each of two separate single inhaled doses in healthy adult participants at two different target peak inspiratory flow rates (PIFRs)
Timeline
- Start
- 2020-11-09
- Primary completion
- 2020-12-14
- Completion
- 2020-12-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | S-770108 | Unknown | 12 mg | Inhaled |
Indications
No indication recorded.